The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.44
Bid: 0.43
Ask: 0.45
Change: 0.00 (0.00%)
Spread: 0.02 (4.651%)
Open: 0.44
High: 0.44
Low: 0.44
Prev. Close: 0.44
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strong Commercial Progress

19 Jun 2018 07:00

RNS Number : 7811R
Haydale Graphene Industries PLC
19 June 2018
 

 

For immediate release

19 June 2018

 

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

Strong commercial progress in graphene-enhanced composites

 

Haydale, (AIM: HAYD), the global advanced materials group, is pleased to announce that strong commercial progress has been made with a global composite materials group (the "Customer") to enhance mechanical properties for selected products in their range of materials, through a commercially funded contract.

 

Over the last 12 months, Haydale has completed a series of pre-production trials for the Customer, who for commercial reasons cannot be named, to enhance these selected products' mechanical performance through the incorporation of graphene in a range of world-wide industrial applications. Haydale understands that the market sector for the Customers' products is significant within the global US$100bn composite market. To date, Haydale has been paid approximately US$150,000 by the Customer for these trials, which is included in the Group's current year revenue expectations. 

 

Trial quantity masterbatches were produced using Haydale's extensive knowledge of the most suitable commercially available graphene in consistent, repeatable quality. The graphene was sourced from an overseas supplier and, using Haydale's considerable in-house dispersion and mixing expertise, the required trial quantity masterbatch was produced. Crucially the trial quantities were specifically designed to be incorporated seamlessly into the Customer's production process.

 

Ray Gibbs, Chief Executive Officer of Haydale, commented: "This contract, fully funded by the Customer, is a perfect example of the work Haydale is doing across a range of composite product applications. We have experienced relatively long lead times with some of our past projects, but this one has been fast-tracked in response to the Customer's desire to launch as soon as possible." 

 

Keith Broadbent, Managing Director of Haydale's Resins, Polymers and Composites strategic business unit, said: "In a relatively short timeframe, Haydale has made excellent progress in delivering on the Customer's needs. It has been pleasing to see Haydale's composite engineers in Loughborough working well with the graphene functionalisation and dispersion team in Ammanford to combine their expertise and turn this major opportunity into a potential industrial product incorporating graphene."

 

- Ends -

 

For further information:

Haydale Graphene Industries plc

Ray Gibbs, Chief Executive Officer

Tel: +44 (0) 1269 842 946

Matt Wood, Finance Director

www.haydale.com

Gemma Smith Head of Marketing

Arden Partners plc (Nominated Adviser & Broker)

Ruari McGirr / Paul Shackleton / Ben Cryer

Tel: +44 (0) 20 7614 5900

 

Media enquiries:

Buchanan

Henry Harrison-Topham / Jamie Hooper /Gemma Mostyn-Owen

Tel: +44 (0) 20 7466 5000

haydale@buchanan.uk.com

www.buchanan.uk.com

 

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from six sites in the UK, USA and the Far East.

 

For more information please visit: www.haydale.com 

Twitter: @haydalegraphene

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAKMGMVRRKGRZM
Date   Source Headline
12th Mar 20247:00 amRNSInterim Results
26th Jan 20247:00 amRNSGrant of Options & Surrender of Existing Options
22nd Jan 20247:00 amRNSHaydale selected for Innovate UK Scaleup Programme
7th Dec 202311:36 amRNSResult of AGM
7th Dec 202311:34 amRNSDirectorate Change
6th Dec 20237:00 amRNSHaydale awarded SMART funding
16th Nov 20232:31 pmRNSHolding(s) in Company
13th Nov 20237:00 amRNSPosting of Annual Report & Notice of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
26th Oct 20237:00 amRNSFinal Results
9th Oct 20238:23 amRNSHolding(s) in Company
5th Oct 20231:43 pmRNSDirector/PDMR Shareholding & Total Voting Rights
4th Oct 20234:46 pmRNSHolding(s) in Company
3rd Oct 20233:48 pmRNSResult of General Meeting
2nd Oct 20237:00 amRNSTotal Voting Rights
22nd Sep 20234:30 pmRNSResult of Retail Offer and Total Voting Rights
15th Sep 20236:12 pmRNSResult of Fundraising
15th Sep 20234:00 pmRNSLaunch of Retail Offer
15th Sep 20233:00 pmRNSProposed Placing, Subscription & Retail Offer
15th Sep 20237:00 amRNSWarrant Expiry, Block Admission Cancellation & TVR
22nd Aug 20237:00 amRNSCollaboration with PETRONAS
4th Aug 20231:02 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSDirectorate Change
24th Jul 20237:00 amRNSContract Award
13th Jul 20237:00 amRNSHaydale Delivers LPHW Prototype for Cadent
21st Jun 20237:00 amRNSTrading Update
5th Jun 20237:00 amRNSDirectorate Change
24th May 20237:00 amRNSHaydale to Contribute to the Development of FCHEVs
3rd May 20237:00 amRNSSMART Innovation to Accelerate Graphene Products
26th Apr 20233:06 pmRNSGrant of Share Options
12th Apr 20237:00 amRNSHaydale and Saint-Gobain Collaborate on hBN
16th Mar 20237:00 amRNSHaydale and City Energy Develop UFH with Plumbase
14th Mar 20238:15 amRNSBlock listing Interim Review
10th Mar 202311:05 amRNSSecond Price Monitoring Extn
10th Mar 202311:00 amRNSPrice Monitoring Extension
10th Mar 20237:00 amRNSDirectorate Change
1st Mar 20237:00 amRNSInterim Results
28th Feb 202311:38 amRNSHaydale and GEIC Proud to Partner for a Sixth Year
21st Feb 20237:00 amRNSRega Turns to Graphene to Improve Sound Quality
14th Feb 20237:00 amRNSInnovate UK Grant to Image 2D Materials Awarded
7th Feb 20237:00 amRNSHaydale Paddles Forward with Norse Kayaks
30th Jan 20237:00 amRNSNotice of Interim Results
26th Jan 20237:00 amRNSCeramycGuard™ on Trial with United Utilities
20th Dec 20227:00 amRNSGraphene-Enhanced Prepreg Extends Tool Life
1st Dec 20227:00 amRNSFinalist for Collaborate to Innovate Awards
30th Nov 20229:22 amRNSGrant of Warrants
29th Nov 20221:55 pmRNSResult of AGM
15th Nov 20227:00 amRNSGrant of share options and PDMR dealings
1st Nov 20227:00 amRNSDirectorate Change and Posting of Annual Report
6th Oct 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.